# Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

> **NCT03287167** · PHASE4 · UNKNOWN · sponsor: **Shanghai MicroPort Medical (Group) Co., Ltd.** · enrollment: 1720 (estimated)

## Conditions studied

- Coronary Disease
- Drug Eluting Stent
- Percutaneous Coronary Intervention
- Dual Antiplatelet Therapy

## Interventions

- **DRUG:** 1 month DAPT
- **DRUG:** 6 months DAPT

## Key facts

- **NCT ID:** NCT03287167
- **Lead sponsor:** Shanghai MicroPort Medical (Group) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2021-07
- **Final completion:** 2023-07-30
- **Target enrollment:** 1720 (ESTIMATED)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03287167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03287167, "Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03287167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*